HEADER MEMBRANE PROTEIN 25-NOV-24 9KQA TITLE CRYO-EM STRUCTURE OF HUMAN VMAT2 IN COMPLEX WITH TETRABENAZINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: SOLUBLE CYTOCHROME B562,SYNAPTIC VESICULAR AMINE COMPND 3 TRANSPORTER; COMPND 4 CHAIN: A; COMPND 5 SYNONYM: CYTOCHROME B-562,MONOAMINE TRANSPORTER,SOLUTE CARRIER FAMILY COMPND 6 18 MEMBER 2,VESICULAR AMINE TRANSPORTER 2,VAT2; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CYBC, SLC18A2, SVMT, VMAT2; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: HEK293 KEYWDS TRANSPORTER, VMAT2, MEMBRANE PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR F.WEI,W.ZHANG,Y.ZHANG REVDAT 1 15-JAN-25 9KQA 0 JRNL AUTH F.WEI,H.LIU,W.ZHANG,J.WANG,Y.ZHANG JRNL TITL DRUG INHIBITION AND SUBSTRATE TRANSPORT MECHANISMS OF HUMAN JRNL TITL 2 VMAT2. JRNL REF NAT COMMUN V. 16 323 2025 JRNL REFN ESSN 2041-1723 JRNL PMID 39747030 JRNL DOI 10.1038/S41467-024-55361-0 REMARK 2 REMARK 2 RESOLUTION. 3.28 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.280 REMARK 3 NUMBER OF PARTICLES : 274059 REMARK 3 CTF CORRECTION METHOD : NONE REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 9KQA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 26-NOV-24. REMARK 100 THE DEPOSITION ID IS D_1300054095. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : VMAT2 REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : 10.00 REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.40 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : TFS KRIOS REMARK 245 DETECTOR TYPE : TFS FALCON 4I (4K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 900.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 1600.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 4823.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : 130000 REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -95 REMARK 465 ALA A -94 REMARK 465 ASP A -93 REMARK 465 LEU A -92 REMARK 465 GLU A -91 REMARK 465 ASP A -90 REMARK 465 ASN A -89 REMARK 465 TRP A -88 REMARK 465 GLU A -87 REMARK 465 THR A -86 REMARK 465 LEU A -85 REMARK 465 ASN A -84 REMARK 465 ASP A -83 REMARK 465 ASN A -82 REMARK 465 LEU A -81 REMARK 465 LYS A -80 REMARK 465 VAL A -79 REMARK 465 ILE A -78 REMARK 465 GLU A -77 REMARK 465 LYS A -76 REMARK 465 ALA A -75 REMARK 465 ASP A -74 REMARK 465 ASN A -73 REMARK 465 ALA A -72 REMARK 465 ALA A -71 REMARK 465 GLN A -70 REMARK 465 VAL A -69 REMARK 465 LYS A -68 REMARK 465 ASP A -67 REMARK 465 ALA A -66 REMARK 465 LEU A -65 REMARK 465 THR A -64 REMARK 465 LYS A -63 REMARK 465 MET A -62 REMARK 465 ARG A -61 REMARK 465 ALA A -60 REMARK 465 ALA A -59 REMARK 465 ALA A -58 REMARK 465 LEU A -57 REMARK 465 ASP A -56 REMARK 465 ALA A -55 REMARK 465 GLN A -54 REMARK 465 LYS A -53 REMARK 465 ALA A -52 REMARK 465 THR A -51 REMARK 465 PRO A -50 REMARK 465 PRO A -49 REMARK 465 LYS A -48 REMARK 465 LEU A -47 REMARK 465 GLU A -46 REMARK 465 ASP A -45 REMARK 465 LYS A -44 REMARK 465 SER A -43 REMARK 465 PRO A -42 REMARK 465 ASP A -41 REMARK 465 SER A -40 REMARK 465 PRO A -39 REMARK 465 GLU A -38 REMARK 465 MET A -37 REMARK 465 LYS A -36 REMARK 465 ASP A -35 REMARK 465 PHE A -34 REMARK 465 ARG A -33 REMARK 465 HIS A -32 REMARK 465 GLY A -31 REMARK 465 PHE A -30 REMARK 465 ASP A -29 REMARK 465 ILE A -28 REMARK 465 LEU A -27 REMARK 465 VAL A -26 REMARK 465 GLY A -25 REMARK 465 GLN A -24 REMARK 465 ILE A -23 REMARK 465 ASP A -22 REMARK 465 ASP A -21 REMARK 465 ALA A -20 REMARK 465 LEU A -19 REMARK 465 LYS A -18 REMARK 465 LEU A -17 REMARK 465 ALA A -16 REMARK 465 ASN A -15 REMARK 465 GLU A -14 REMARK 465 GLY A -13 REMARK 465 LYS A -12 REMARK 465 VAL A -11 REMARK 465 LYS A -10 REMARK 465 GLU A -9 REMARK 465 ALA A -8 REMARK 465 GLN A -7 REMARK 465 ALA A -6 REMARK 465 ALA A -5 REMARK 465 ALA A -4 REMARK 465 GLU A -3 REMARK 465 GLN A -2 REMARK 465 LEU A -1 REMARK 465 LYS A 0 REMARK 465 THR A 1 REMARK 465 THR A 2 REMARK 465 ARG A 3 REMARK 465 ASN A 4 REMARK 465 ALA A 5 REMARK 465 TYR A 6 REMARK 465 ILE A 7 REMARK 465 GLN A 8 REMARK 465 LYS A 9 REMARK 465 TYR A 10 REMARK 465 LEU A 11 REMARK 465 LEU A 12 REMARK 465 GLN A 13 REMARK 465 GLU A 14 REMARK 465 SER A 15 REMARK 465 ILE A 51 REMARK 465 LYS A 52 REMARK 465 HIS A 53 REMARK 465 GLU A 54 REMARK 465 LYS A 55 REMARK 465 ASN A 56 REMARK 465 ALA A 57 REMARK 465 THR A 58 REMARK 465 GLU A 59 REMARK 465 ILE A 60 REMARK 465 GLN A 61 REMARK 465 THR A 62 REMARK 465 ALA A 63 REMARK 465 ARG A 64 REMARK 465 PRO A 65 REMARK 465 VAL A 66 REMARK 465 HIS A 67 REMARK 465 THR A 68 REMARK 465 ALA A 69 REMARK 465 SER A 70 REMARK 465 ILE A 71 REMARK 465 SER A 72 REMARK 465 ASP A 73 REMARK 465 SER A 74 REMARK 465 PHE A 75 REMARK 465 GLN A 76 REMARK 465 SER A 77 REMARK 465 ILE A 78 REMARK 465 PHE A 79 REMARK 465 SER A 80 REMARK 465 TYR A 81 REMARK 465 TYR A 82 REMARK 465 ASP A 83 REMARK 465 ASN A 84 REMARK 465 SER A 85 REMARK 465 THR A 86 REMARK 465 MET A 87 REMARK 465 VAL A 88 REMARK 465 THR A 89 REMARK 465 GLY A 90 REMARK 465 ASN A 91 REMARK 465 ALA A 92 REMARK 465 THR A 93 REMARK 465 ARG A 94 REMARK 465 ASP A 95 REMARK 465 LEU A 96 REMARK 465 THR A 97 REMARK 465 LEU A 98 REMARK 465 HIS A 99 REMARK 465 GLN A 100 REMARK 465 THR A 101 REMARK 465 ALA A 102 REMARK 465 THR A 103 REMARK 465 GLN A 104 REMARK 465 HIS A 105 REMARK 465 MET A 106 REMARK 465 VAL A 107 REMARK 465 THR A 108 REMARK 465 ASN A 109 REMARK 465 ALA A 110 REMARK 465 SER A 111 REMARK 465 ALA A 112 REMARK 465 VAL A 113 REMARK 465 PRO A 114 REMARK 465 SER A 115 REMARK 465 ASP A 116 REMARK 465 CYS A 117 REMARK 465 PRO A 118 REMARK 465 SER A 119 REMARK 465 GLU A 120 REMARK 465 ASP A 121 REMARK 465 LYS A 122 REMARK 465 ASP A 123 REMARK 465 LEU A 124 REMARK 465 LEU A 125 REMARK 465 MET A 319 REMARK 465 MET A 320 REMARK 465 GLU A 321 REMARK 465 THR A 322 REMARK 465 MET A 323 REMARK 465 CYS A 324 REMARK 465 SER A 325 REMARK 465 ARG A 326 REMARK 465 LYS A 327 REMARK 465 GLU A 477 REMARK 465 GLU A 478 REMARK 465 LYS A 479 REMARK 465 MET A 480 REMARK 465 ALA A 481 REMARK 465 ILE A 482 REMARK 465 LEU A 483 REMARK 465 MET A 484 REMARK 465 ASP A 485 REMARK 465 HIS A 486 REMARK 465 ASN A 487 REMARK 465 CYS A 488 REMARK 465 PRO A 489 REMARK 465 ILE A 490 REMARK 465 LYS A 491 REMARK 465 THR A 492 REMARK 465 LYS A 493 REMARK 465 MET A 494 REMARK 465 TYR A 495 REMARK 465 THR A 496 REMARK 465 GLN A 497 REMARK 465 ASN A 498 REMARK 465 ASN A 499 REMARK 465 ILE A 500 REMARK 465 GLN A 501 REMARK 465 SER A 502 REMARK 465 TYR A 503 REMARK 465 PRO A 504 REMARK 465 ILE A 505 REMARK 465 GLY A 506 REMARK 465 GLU A 507 REMARK 465 ASP A 508 REMARK 465 GLU A 509 REMARK 465 GLU A 510 REMARK 465 SER A 511 REMARK 465 GLU A 512 REMARK 465 SER A 513 REMARK 465 ASP A 514 REMARK 465 HIS A 515 REMARK 465 HIS A 516 REMARK 465 HIS A 517 REMARK 465 HIS A 518 REMARK 465 HIS A 519 REMARK 465 HIS A 520 REMARK 465 HIS A 521 REMARK 465 HIS A 522 REMARK 465 HIS A 523 REMARK 465 HIS A 524 REMARK 465 GLY A 525 REMARK 465 SER A 526 REMARK 465 VAL A 527 REMARK 465 GLU A 528 REMARK 465 ASP A 529 REMARK 465 TYR A 530 REMARK 465 LYS A 531 REMARK 465 ASP A 532 REMARK 465 ASP A 533 REMARK 465 ASP A 534 REMARK 465 ASP A 535 REMARK 465 LYS A 536 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 16 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 17 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 20 CG CD CE NZ REMARK 470 TYR A 49 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ASN A 126 CG OD1 ND2 REMARK 470 GLU A 127 CG CD OE1 OE2 REMARK 470 GLU A 215 CG CD OE1 OE2 REMARK 470 GLU A 244 CG CD OE1 OE2 REMARK 470 LEU A 260 CG CD1 CD2 REMARK 470 LEU A 267 CG CD1 CD2 REMARK 470 ARG A 274 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 276 CG CD OE1 NE2 REMARK 470 LYS A 281 CG CD CE NZ REMARK 470 MET A 355 CG SD CE REMARK 470 LYS A 445 CG CD CE NZ REMARK 470 LYS A 476 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 42 1.31 -67.32 REMARK 500 ASP A 214 -78.22 -78.44 REMARK 500 GLN A 271 72.58 53.58 REMARK 500 SER A 273 2.30 -66.26 REMARK 500 PRO A 313 1.53 -66.13 REMARK 500 GLN A 329 0.02 -67.06 REMARK 500 LEU A 384 0.25 -63.44 REMARK 500 PRO A 450 -9.11 -56.16 REMARK 500 PHE A 469 4.69 -68.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-62498 RELATED DB: EMDB REMARK 900 CRYO-EM STRUCTURE OF HUMAN VMAT2 IN COMPLEX WITH TETRABENAZINE DBREF 9KQA A -94 11 UNP P0ABE7 C562_ECOLX 23 128 DBREF 9KQA A 12 514 UNP Q05940 VMAT2_HUMAN 12 514 SEQADV 9KQA MET A -95 UNP P0ABE7 INITIATING METHIONINE SEQADV 9KQA TRP A -88 UNP P0ABE7 MET 29 ENGINEERED MUTATION SEQADV 9KQA ILE A 7 UNP P0ABE7 HIS 124 ENGINEERED MUTATION SEQADV 9KQA LEU A 11 UNP P0ABE7 ARG 128 ENGINEERED MUTATION SEQADV 9KQA HIS A 515 UNP Q05940 EXPRESSION TAG SEQADV 9KQA HIS A 516 UNP Q05940 EXPRESSION TAG SEQADV 9KQA HIS A 517 UNP Q05940 EXPRESSION TAG SEQADV 9KQA HIS A 518 UNP Q05940 EXPRESSION TAG SEQADV 9KQA HIS A 519 UNP Q05940 EXPRESSION TAG SEQADV 9KQA HIS A 520 UNP Q05940 EXPRESSION TAG SEQADV 9KQA HIS A 521 UNP Q05940 EXPRESSION TAG SEQADV 9KQA HIS A 522 UNP Q05940 EXPRESSION TAG SEQADV 9KQA HIS A 523 UNP Q05940 EXPRESSION TAG SEQADV 9KQA HIS A 524 UNP Q05940 EXPRESSION TAG SEQADV 9KQA GLY A 525 UNP Q05940 EXPRESSION TAG SEQADV 9KQA SER A 526 UNP Q05940 EXPRESSION TAG SEQADV 9KQA VAL A 527 UNP Q05940 EXPRESSION TAG SEQADV 9KQA GLU A 528 UNP Q05940 EXPRESSION TAG SEQADV 9KQA ASP A 529 UNP Q05940 EXPRESSION TAG SEQADV 9KQA TYR A 530 UNP Q05940 EXPRESSION TAG SEQADV 9KQA LYS A 531 UNP Q05940 EXPRESSION TAG SEQADV 9KQA ASP A 532 UNP Q05940 EXPRESSION TAG SEQADV 9KQA ASP A 533 UNP Q05940 EXPRESSION TAG SEQADV 9KQA ASP A 534 UNP Q05940 EXPRESSION TAG SEQADV 9KQA ASP A 535 UNP Q05940 EXPRESSION TAG SEQADV 9KQA LYS A 536 UNP Q05940 EXPRESSION TAG SEQRES 1 A 632 MET ALA ASP LEU GLU ASP ASN TRP GLU THR LEU ASN ASP SEQRES 2 A 632 ASN LEU LYS VAL ILE GLU LYS ALA ASP ASN ALA ALA GLN SEQRES 3 A 632 VAL LYS ASP ALA LEU THR LYS MET ARG ALA ALA ALA LEU SEQRES 4 A 632 ASP ALA GLN LYS ALA THR PRO PRO LYS LEU GLU ASP LYS SEQRES 5 A 632 SER PRO ASP SER PRO GLU MET LYS ASP PHE ARG HIS GLY SEQRES 6 A 632 PHE ASP ILE LEU VAL GLY GLN ILE ASP ASP ALA LEU LYS SEQRES 7 A 632 LEU ALA ASN GLU GLY LYS VAL LYS GLU ALA GLN ALA ALA SEQRES 8 A 632 ALA GLU GLN LEU LYS THR THR ARG ASN ALA TYR ILE GLN SEQRES 9 A 632 LYS TYR LEU LEU GLN GLU SER ARG ARG SER ARG LYS LEU SEQRES 10 A 632 ILE LEU PHE ILE VAL PHE LEU ALA LEU LEU LEU ASP ASN SEQRES 11 A 632 MET LEU LEU THR VAL VAL VAL PRO ILE ILE PRO SER TYR SEQRES 12 A 632 LEU TYR SER ILE LYS HIS GLU LYS ASN ALA THR GLU ILE SEQRES 13 A 632 GLN THR ALA ARG PRO VAL HIS THR ALA SER ILE SER ASP SEQRES 14 A 632 SER PHE GLN SER ILE PHE SER TYR TYR ASP ASN SER THR SEQRES 15 A 632 MET VAL THR GLY ASN ALA THR ARG ASP LEU THR LEU HIS SEQRES 16 A 632 GLN THR ALA THR GLN HIS MET VAL THR ASN ALA SER ALA SEQRES 17 A 632 VAL PRO SER ASP CYS PRO SER GLU ASP LYS ASP LEU LEU SEQRES 18 A 632 ASN GLU ASN VAL GLN VAL GLY LEU LEU PHE ALA SER LYS SEQRES 19 A 632 ALA THR VAL GLN LEU ILE THR ASN PRO PHE ILE GLY LEU SEQRES 20 A 632 LEU THR ASN ARG ILE GLY TYR PRO ILE PRO ILE PHE ALA SEQRES 21 A 632 GLY PHE CYS ILE MET PHE VAL SER THR ILE MET PHE ALA SEQRES 22 A 632 PHE SER SER SER TYR ALA PHE LEU LEU ILE ALA ARG SER SEQRES 23 A 632 LEU GLN GLY ILE GLY SER SER CYS SER SER VAL ALA GLY SEQRES 24 A 632 MET GLY MET LEU ALA SER VAL TYR THR ASP ASP GLU GLU SEQRES 25 A 632 ARG GLY ASN VAL MET GLY ILE ALA LEU GLY GLY LEU ALA SEQRES 26 A 632 MET GLY VAL LEU VAL GLY PRO PRO PHE GLY SER VAL LEU SEQRES 27 A 632 TYR GLU PHE VAL GLY LYS THR ALA PRO PHE LEU VAL LEU SEQRES 28 A 632 ALA ALA LEU VAL LEU LEU ASP GLY ALA ILE GLN LEU PHE SEQRES 29 A 632 VAL LEU GLN PRO SER ARG VAL GLN PRO GLU SER GLN LYS SEQRES 30 A 632 GLY THR PRO LEU THR THR LEU LEU LYS ASP PRO TYR ILE SEQRES 31 A 632 LEU ILE ALA ALA GLY SER ILE CYS PHE ALA ASN MET GLY SEQRES 32 A 632 ILE ALA MET LEU GLU PRO ALA LEU PRO ILE TRP MET MET SEQRES 33 A 632 GLU THR MET CYS SER ARG LYS TRP GLN LEU GLY VAL ALA SEQRES 34 A 632 PHE LEU PRO ALA SER ILE SER TYR LEU ILE GLY THR ASN SEQRES 35 A 632 ILE PHE GLY ILE LEU ALA HIS LYS MET GLY ARG TRP LEU SEQRES 36 A 632 CYS ALA LEU LEU GLY MET ILE ILE VAL GLY VAL SER ILE SEQRES 37 A 632 LEU CYS ILE PRO PHE ALA LYS ASN ILE TYR GLY LEU ILE SEQRES 38 A 632 ALA PRO ASN PHE GLY VAL GLY PHE ALA ILE GLY MET VAL SEQRES 39 A 632 ASP SER SER MET MET PRO ILE MET GLY TYR LEU VAL ASP SEQRES 40 A 632 LEU ARG HIS VAL SER VAL TYR GLY SER VAL TYR ALA ILE SEQRES 41 A 632 ALA ASP VAL ALA PHE CYS MET GLY TYR ALA ILE GLY PRO SEQRES 42 A 632 SER ALA GLY GLY ALA ILE ALA LYS ALA ILE GLY PHE PRO SEQRES 43 A 632 TRP LEU MET THR ILE ILE GLY ILE ILE ASP ILE LEU PHE SEQRES 44 A 632 ALA PRO LEU CYS PHE PHE LEU ARG SER PRO PRO ALA LYS SEQRES 45 A 632 GLU GLU LYS MET ALA ILE LEU MET ASP HIS ASN CYS PRO SEQRES 46 A 632 ILE LYS THR LYS MET TYR THR GLN ASN ASN ILE GLN SER SEQRES 47 A 632 TYR PRO ILE GLY GLU ASP GLU GLU SER GLU SER ASP HIS SEQRES 48 A 632 HIS HIS HIS HIS HIS HIS HIS HIS HIS GLY SER VAL GLU SEQRES 49 A 632 ASP TYR LYS ASP ASP ASP ASP LYS HET EBZ A 601 23 HETNAM EBZ (3S,5R,11BS)-9,10-DIMETHOXY-3-(2-METHYLPROPYL)-1,3,4,6, HETNAM 2 EBZ 7,11B-HEXAHYDRO-2H-PYRIDO[2,1-A]ISOQUINOLIN-2-ONE FORMUL 2 EBZ C19 H27 N O3 HELIX 1 AA1 SER A 18 VAL A 39 1 22 HELIX 2 AA2 VAL A 40 ILE A 43 5 4 HELIX 3 AA3 ILE A 44 TYR A 49 1 6 HELIX 4 AA4 VAL A 129 GLY A 157 1 29 HELIX 5 AA5 TYR A 158 PHE A 178 1 21 HELIX 6 AA6 SER A 181 TYR A 211 1 31 HELIX 7 AA7 ASP A 213 VAL A 246 1 34 HELIX 8 AA8 LYS A 248 LEU A 270 1 23 HELIX 9 AA9 PRO A 284 ASP A 291 1 8 HELIX 10 AB1 ASP A 291 GLU A 312 1 22 HELIX 11 AB2 PHE A 334 ALA A 352 1 19 HELIX 12 AB3 GLY A 356 ILE A 375 1 20 HELIX 13 AB4 LEU A 384 HIS A 414 1 31 HELIX 14 AB5 TYR A 418 MET A 431 1 14 HELIX 15 AB6 MET A 431 GLY A 436 1 6 HELIX 16 AB7 GLY A 436 GLY A 448 1 13 HELIX 17 AB8 GLY A 448 ALA A 464 1 17 HELIX 18 AB9 PRO A 465 ARG A 471 5 7 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 CONECT 2762 2765 2773 2784 CONECT 2763 2765 2781 CONECT 2764 2766 2781 CONECT 2765 2762 2763 2775 CONECT 2766 2764 2772 CONECT 2767 2769 2774 2782 CONECT 2768 2769 2772 CONECT 2769 2767 2768 2783 CONECT 2770 2771 2773 2781 CONECT 2771 2770 2772 2774 CONECT 2772 2766 2768 2771 CONECT 2773 2762 2770 CONECT 2774 2767 2771 CONECT 2775 2765 2776 CONECT 2776 2775 2779 2780 CONECT 2777 2782 CONECT 2778 2783 CONECT 2779 2776 CONECT 2780 2776 CONECT 2781 2763 2764 2770 CONECT 2782 2767 2777 CONECT 2783 2769 2778 CONECT 2784 2762 MASTER 406 0 1 18 0 0 0 6 2783 1 23 49 END